These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21874304)

  • 1. Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy.
    van de Ven R; Reurs AW; Wijnands PGJTB; van Wetering S; Kruisbeek AM; Hooijberg E; Scheffer GL; Scheper RJ; de Gruijl TD
    Cancer Immunol Immunother; 2012 Feb; 61(2):181-191. PubMed ID: 21874304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPA/uPAR system is active in immature dendritic cells derived from CD14+CD34+ precursors and is down-regulated upon maturation.
    Ferrero E; Vettoretto K; Bondanza A; Villa A; Resnati M; Poggi A; Zocchi MR
    J Immunol; 2000 Jan; 164(2):712-8. PubMed ID: 10623814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
    Hansen M; Met Ö; Larsen NB; Rosenkilde MM; Andersen MH; Svane IM; Hjortø GM
    Cytotherapy; 2016 Sep; 18(9):1187-96. PubMed ID: 27424146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses.
    Santiago-Schwarz F; Anand P; Liu S; Carsons SE
    J Immunol; 2001 Aug; 167(3):1758-68. PubMed ID: 11466401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development.
    Woltman AM; Massacrier C; de Fijter JW; Caux C; van Kooten C
    J Immunol; 2002 Jun; 168(12):6181-8. PubMed ID: 12055231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.
    Hutten T; Thordardottir S; Hobo W; Hübel J; van der Waart AB; Cany J; Dolstra H; Hangalapura BN
    J Immunother; 2014 Jun; 37(5):267-77. PubMed ID: 24810638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model.
    van de Ven R; Verbrugge SE; Reurs AW; Bontkes HJ; Hooijberg E; Jansen G; Scheper RJ; Scheffer GL; de Gruijl TD
    Cancer Immunol Immunother; 2011 Jul; 60(7):943-51. PubMed ID: 21431918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
    Canque B; Camus S; Yagello M; Gluckman JC
    J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
    Santegoets SJ; Masterson AJ; van der Sluis PC; Lougheed SM; Fluitsma DM; van den Eertwegh AJ; Pinedo HM; Scheper RJ; de Gruijl TD
    J Leukoc Biol; 2006 Dec; 80(6):1337-44. PubMed ID: 16959899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.
    Ferlazzo G; Wesa A; Wei WZ; Galy A
    J Immunol; 1999 Oct; 163(7):3597-604. PubMed ID: 10490952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation.
    Sombroek CC; Stam AG; Masterson AJ; Lougheed SM; Schakel MJ; Meijer CJ; Pinedo HM; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
    J Immunol; 2002 May; 168(9):4333-43. PubMed ID: 11970975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dendritic cells for cancer vaccination.
    Esche C; Shurin MR; Lotze MT
    Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.
    Ruben JM; van den Ancker W; Bontkes HJ; Westers TM; Hooijberg E; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA
    Cancer Immunol Immunother; 2014 Apr; 63(4):335-45. PubMed ID: 24384837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor.
    Arrighi JF; Hauser C; Chapuis B; Zubler RH; Kindler V
    Blood; 1999 Apr; 93(7):2244-52. PubMed ID: 10090933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
    Dilioglou S; Cruse JM; Lewis RE
    Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.
    Balan S; Ollion V; Colletti N; Chelbi R; Montanana-Sanchis F; Liu H; Vu Manh TP; Sanchez C; Savoret J; Perrot I; Doffin AC; Fossum E; Bechlian D; Chabannon C; Bogen B; Asselin-Paturel C; Shaw M; Soos T; Caux C; Valladeau-Guilemond J; Dalod M
    J Immunol; 2014 Aug; 193(4):1622-35. PubMed ID: 25009205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.